Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company developing oral medicines using targeted protein degradation (TPD) technology to address diseases with unmet medical needs. The company focuses on immunology, targeting immune-inflammatory conditions in the United States, Europe, and Japan.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.